AVXL Investors: Anavex Life Sciences Corp. Shares Declined By $0.19 On August 31, 2026 — Contact Kirby McInerney LLP to Discuss Your Rights

For best results when printing this announcement, please click on link below: AVXL Investors: Anavex Life Sciences Corp. 19 On August 31, 2026 — Contact Kirby McInerney LLP to Discuss Your Rights If you have suffered a loss on your Anavex Life Sciences Corp. com), or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost. Investors have until November 30, 2026 to ask the Court to appoint them as lead plaintiff.

[CONTACT THE FIRM IF YOU SUFFERED A LOSS ] What Is The Lawsuit About? The lawsuit has been filed on behalf of investors who purchased securities during the period of November 26, 2025 through August 28, 2026, inclusive (“the Class Period”). The lawsuit alleges that Anavex made false and/or misleading statements and failed to disclose that: (i) Anavex lacked adequate internal controls; and (ii) Anavex understated its potential regulatory challenges as a result of misconduct by former CEO Christopher Missling.

On May 6, 2026, Anavex filed a report on Form 8-K with the SEC, disclosing that, on April 30, 2026, a special committee of Anavex Board of Directors “terminated the employment” of the Company’s Chief Executive Officer Christopher Missling. 34 on May 6, 2026. Then, on May 11, 2026, Anavex filed with the SEC a notification of late filing on Form 12-25, which stated that the Company was unable to file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2026 by the prescribed May 11, 2026 due date.

The Company attributed this to the termination of CEO Missling, stating, “Until the Special Committee and the Company complete their review of certain matters related to the termination of Dr. 06 on May 12, 2026. Finally, on August 28, 2026, Anavex filed with the SEC an amended Annual Report on Form 10-K/A for the fiscal year ended September 30, 2025. 80 on August 31, 2026.

[CLICK HERE TO LEARN MORE ABOUT THE LAWSUIT ] What Are My Options? Courts do not consider applications filed after the relevant deadline. The lead plaintiff oversees the litigation on behalf of the class and may influence key decisions, including litigation strategy and settlement. Courts regularly appoint individual investors as lead plaintiffs, not only institutions.

Learn more about the lead plaintiff process and eligibility requirements here [WHAT IS A SECURITIES CLASS ACTION? ] Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found on Kirby McInerney LLP’s website This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

com: Kirby McInerney LLP Lauren Molinaro, Esq. com)